AAAAAA
Results:
1-7
|
Results: 7
Authors:
Pakes, GE
Citation: Ge. Pakes, Writing manuscripts describing clinical trials: A guide for pharmacotherapeutic researchers, ANN PHARMAC, 35(6), 2001, pp. 770-779
Authors:
DeMasi, RA
Graham, NM
Tolson, JM
Pham, SV
Capuano, GA
Fisher, RL
Shaefer, MS
Pakes, GE
Sawyerr, GA
Eron, JJ
Citation: Ra. Demasi et al., Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome, ADV THER, 18(4), 2001, pp. 163-173
Authors:
Moodley, D
Pillay, K
Naidoo, K
Moodley, J
Johnson, MA
Moore, KHP
Mudd, PN
Pakes, GE
Citation: D. Moodley et al., Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours, J CLIN PHAR, 41(7), 2001, pp. 732-741
Authors:
Johnson, MA
Moore, KHP
Yuen, GJ
Bye, A
Pakes, GE
Citation: Ma. Johnson et al., Clinical pharmacokinetics of lamivudine, CLIN PHARMA, 36(1), 1999, pp. 41-66
Authors:
Moore, KHP
Barrett, JE
Shaw, S
Pakes, GE
Churchus, R
Kapoor, A
Lloyd, J
Barry, MG
Back, D
Citation: Khp. Moore et al., The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1, AIDS, 13(16), 1999, pp. 2239-2250
Authors:
Moore, KHP
Shaw, S
Laurent, AL
Lloyd, P
Duncan, B
Morris, DM
O'Mara, MJ
Pakes, GE
Citation: Khp. Moore et al., Lamivudine zidovudine as a combined formulation tablet: Bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption, J CLIN PHAR, 39(6), 1999, pp. 593-605
Authors:
Moore, KHP
Yuen, GJ
Hussey, EK
Pakes, GE
Eron, JJ
Bartlett, JA
Citation: Khp. Moore et al., Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials, ANTIM AG CH, 43(12), 1999, pp. 3025-3029
Risultati:
1-7
|